Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
275.67
228.46
194.62
153.28
122.49
113.24
85.75
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
275.67
228.46
194.62
153.28
122.49
113.24
85.75
Raw Material Cost
78.53
63.26
43.31
33.47
24.62
20.26
18.59
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
75.96
0.00
0.00
0.00
0.00
34.76
57.67
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.16
2.41
1.93
0.61
0.13
0.15
0.09
Selling and Distribution Expenses
95.20
96.96
96.15
68.39
56.89
63.42
78.15
Other Expenses
-5.21
2.19
2.60
2.35
1.47
-1.87
-3.91
Total Expenditure (Excl Depreciation)
198.79
184.53
167.42
125.94
96.36
99.85
115.45
Operating Profit (PBDIT) excl Other Income
76.9
43.9
27.200000000000003
27.3
26.099999999999998
13.4
-29.700000000000003
Other Income
20.05
8.29
16.43
24.31
17.47
18.44
11.41
Operating Profit (PBDIT)
122.57
76.86
58.71
60.88
49.16
36.49
-14.75
Interest
1.16
2.41
1.93
0.61
0.13
0.15
0.09
Exceptional Items
-0.33
0.13
-0.31
0.98
0.40
0.73
0.00
Gross Profit (PBDT)
197.14
165.21
151.32
119.81
97.87
92.98
67.17
Depreciation
27.91
26.55
16.51
9.65
6.43
6.01
4.80
Profit Before Tax
93.16
48.02
39.96
51.60
43.00
31.06
-19.65
Tax
14.30
7.14
4.23
6.92
6.15
3.48
-0.92
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
78.85
40.88
35.89
44.71
36.97
27.68
-18.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
78.85
40.88
35.89
44.71
36.97
27.68
-18.59
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
-0.16
-0.03
-0.11
-0.10
-0.14
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
78.85
40.88
35.73
44.68
36.86
27.58
-18.73
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
699.66
635.86
602.58
572.26
334.43
299.03
271.35
Earnings per share (EPS)
1.19
0.62
0.54
0.68
0.56
0.42
-0.28
Diluted Earnings per share
1.19
0.62
0.54
0.68
0.56
0.42
-0.28
Operating Profit Margin (Excl OI)
27.06%
18.39%
13.24%
17.57%
20.62%
10.63%
-36.12%
Gross Profit Margin
43.92%
32.64%
29.02%
39.96%
40.36%
32.74%
-17.31%
PAT Margin
28.6%
17.89%
18.44%
29.17%
30.18%
24.44%
-21.68%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2024 is 20.66% vs 17.42% in Dec 2023
Consolidate Net Profit
YoY Growth in year ended Dec 2024 is 92.91% vs 14.57% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2024 is 49.42% vs 62.17% in Dec 2023
Interest
YoY Growth in year ended Dec 2024 is -50.00% vs 26.32% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2024 has improved from Dec 2023
Compare Annual Results Of Medprin Regenerative Medical Technologies Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
275.67
0
275.67
Other Operating Income
0.00
0.00
0.00
Total Operating income
275.67
0
275.67
Raw Material Cost
78.53
0
78.53
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
75.96
0
75.96
Power Cost
0
0
0.00
Manufacturing Expenses
1.16
0
1.16
Selling and Distribution Expenses
95.20
0
95.20
Other Expenses
-5.21
0.00
-5.21
Total Expenditure (Excl Depreciation)
198.79
0
198.79
Operating Profit (PBDIT) excl Other Income
76.88
0.00
76.88
Other Income
20.05
0
20.05
Operating Profit (PBDIT)
122.57
0
122.57
Interest
1.16
0
1.16
Exceptional Items
-0.33
0
-0.33
Gross Profit (PBDT)
197.14
0
197.14
Depreciation
27.91
0
27.91
Profit Before Tax
93.16
0
93.16
Tax
14.30
0
14.30
Provisions and contingencies
0
0
0.00
Profit After Tax
78.85
0
78.85
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
78.85
0
78.85
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
78.85
0
78.85
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
699.66
0
699.66
Earnings per share (EPS)
1.19
0
1.19
Diluted Earnings per share
1.19
0
1.19
Operating Profit Margin (Excl OI)
27.06%
0%
0.00
27.06%
Gross Profit Margin
43.92%
0%
0.00
43.92%
PAT Margin
28.60%
0%
0.00
28.60%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 27.57 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 20.66% vs 17.42% in Dec 2023
Annual - Consolidate Net Profit
Consolidate Net Profit 7.89 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 92.91% vs 14.57% in Dec 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.25 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is 49.42% vs 62.17% in Dec 2023
Annual - Interest
Interest 0.12 Million
in Dec 2024Figures in Million
YoY Growth in year ended Dec 2024 is -50.00% vs 26.32% in Dec 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.06%
in Dec 2024Figures in %
YoY Growth in year ended Dec 2024 has improved from Dec 2023






